Cystatin C and the misdiagnosis of CKD in older adults

IF 28.6 1区医学 Q1 UROLOGY & NEPHROLOGY

Nature Reviews Nephrology Pub Date : 2024-06-03 DOI:10.1038/s41581-024-00852-y

Andrew D. Rule, Richard J. Glassock

引用次数: 0

Abstract

The use of cystatin C-inclusive equations will continue to propagate the unnecessary overdiagnosis of chronic kidney disease (CKD) in older people. Cystatin C is less biologically specific for CKD than is serum creatinine, inflates the risks of adverse outcomes compared to measured glomerular filtration rate, and does not establish chronicity at a single time point.

Abstract Image

查看原文本刊更多论文

胱抑素 C 与老年人慢性肾功能衰竭的误诊

使用包含胱抑素 C 的方程将继续助长对老年人慢性肾病（CKD）不必要的过度诊断。与血清肌酐相比，胱抑素 C 对慢性肾脏病的生物特异性较差，与测量的肾小球滤过率相比，胱抑素 C 会增加不良后果的风险，而且不能在单一时间点确定慢性肾脏病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Nephrology 医学-泌尿学与肾脏学

CiteScore

39.00

自引率

1.20%

发文量

127

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Nephrology aims to be the premier source of reviews and commentaries for the scientific communities it serves. It strives to publish authoritative, accessible articles. Articles are enhanced with clearly understandable figures, tables, and other display items. Nature Reviews Nephrology publishes Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements. The content is relevant to nephrologists and basic science researchers. The broad scope of the journal ensures that the work reaches the widest possible audience.